Bank of New York Mellon Corp - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 79 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2015. The put-call ratio across all filers is 4.28 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$66,328,000
+17.5%
586,459
+4.1%
0.02%
+18.8%
Q1 2017$56,426,000
-1.4%
563,527
+5.9%
0.02%0.0%
Q4 2016$57,226,000
-14.5%
532,230
-1.0%
0.02%
-20.0%
Q3 2016$66,894,000
+24.0%
537,406
+5.9%
0.02%
+25.0%
Q2 2016$53,959,000
-0.4%
507,518
+7.3%
0.02%0.0%
Q1 2016$54,173,000
+1.6%
473,210
+26.4%
0.02%0.0%
Q4 2015$53,327,000
+54.5%
374,328
-2.6%
0.02%
+45.5%
Q3 2015$34,507,000
+29.9%
384,180
+66.5%
0.01%
+57.1%
Q2 2015$26,573,000
+565.7%
230,736
+452.1%
0.01%
+600.0%
Q1 2015$3,992,000
+435.8%
41,796
+277.2%
0.00%
Q4 2014$745,00011,0810.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Segantii Capital Management Ltd 50,000$5,288,0005.80%
RUDMAN ERROL M 37,001$3,934,0003.76%
INDUS CAPITAL PARTNERS, LLC 349,210$37,128,0003.60%
WARBURG PINCUS LLC 1,312,200$139,513,0003.04%
SPQ Asia Capital Ltd 96,000$10,206,0002.63%
OBERWEIS ASSET MANAGEMENT INC/ 82,775$8,801,0002.62%
Ativo Capital Management LLC 94,074$10,002,0002.44%
Sensato Investors LLC 99,764$10,607,0001.72%
Cormorant Asset Management, LP 112,867$12,000,0001.70%
BARING ASSET MANAGEMENT Ltd 131,284$13,958,0001.14%
View complete list of CHINA BIOLOGIC PRODS INC shareholders